NICE Approves SpaceOAR Hydrogel Use in UK

NICE Approves SpaceOAR Hydrogel Use in UK
The National Institute for Health and Care Excellence (NICE) in the U.K. has issued a guidance for prostate cancer care that supports the use of SpaceOAR hydrogel as a protective barrier to reduce the risk of radiation damage to healthy tissues and other organs during radiation therapy. NICE’s Interventional Procedure Guidance (IPG) now allows U.K. radiation oncologists and urologists to offer patients the option of using a hydrogel spacer like SpaceOAR to reduce the risk of radiotherapy-related side effects, including incontinence, loss of sexual function, and rectal dysfunction. SpaceOAR hydrogel was developed by 
Subscribe or to access all post and page content.